FOR RESEARCH PURPOSES ONLY — Not for human consumption.
GLP-3 (RT)
GLP-3 (RT) is a room-temperature stable formulation of glucagon-like peptide-3, studied for its role in GLP-receptor binding and incretin-pathway signaling research. The RT formulation allows for easier handling and storage in research settings. For research use only.
- GLP-receptor signaling research
- Incretin pathway studies
- Peptide stability research
Storage Requirements
Stability information
Molecular Profile
Technical specifications
Peer Reviewed Research
Published scientific literature
Molecular Metabolism
2019
Glucagon-like peptide 1 (GLP-1)
Müller TD, et al.
Cell Metabolism
2018
Mechanisms of action and therapeutic application of glucagon-like peptide-1
Drucker DJ
Diabetes, Obesity and Metabolism
2018
Incretin hormones: their role in health and disease
Nauck MA, Meier JJ
Nature Metabolism
2024
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Diabetes, Obesity and Metabolism
2021
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update
Nauck MA, et al.
Certificate of Analysis
Third-party tested · ISO/IEC 17025 Accredited
GLP-3 (RT) 30mg
Lot #ORV-003
99.3%
Purity
Labeled
30mg
Actual
30.4mg
Tested
May 5, 2026
Full QC Panel
Important Research Notice
Not for human consumption. This product is sold exclusively for in-vitro research and laboratory purposes. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
All research findings and citations presented on this page are sourced from peer-reviewed journals and publicly available publications. They are provided for educational and scientific reference only and do not constitute medical advice or product claims.
By purchasing this product you confirm you are a qualified researcher and will use it in full compliance with all applicable federal, state, and local laws and regulations.
Stay ahead of the research
Subscribe for catalog updates, new research compounds, and quality documentation news.
For researchers and labs. No spam, unsubscribe anytime.